Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells

International Journal of Hematology

Volumn 87, Issue 1, 2008, Pages 39-47

  Koldehoff, Michael ^a   Zakrzewski, Johannes L ^b   Klein Hitpass, Ludger ^c   Beelen, Dietrich W ^a   Elmaagacli, Ahmet H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Memorial Sloan Kettering   (United States)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Gfi 1B; Hematopoietic; K562; Microarray analysis; Small interfering RNA

Indexed keywords

ATAXIN 3; ATR PROTEIN; CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 65; GROWTH FACTOR INDEPENDENT 1B; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT 3L; HEAT SHOCK PROTEIN 90; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MYC PROTEIN; PHOSPHOLIPASE D1; PROTEIN BCL11B; PROTEIN TMEM30; PROTEIN TYROSINE KINASE; RAC 3 PROTEIN; RAC PROTEIN; RETINOIC ACID RECEPTOR ALPHA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ATR; TRANSCRIPTION FACTOR CEP290; TRANSCRIPTION FACTOR GTF2H3; TRANSCRIPTION FACTOR JEM1; TRANSCRIPTION FACTOR RBBP6; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROID CELL; GENE OVEREXPRESSION; GENE SILENCING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; MEGAKARYOCYTE; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE MYC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 41849138303     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-007-0013-z     Document Type: Article

References (31)

1. Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAP, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Bio. 1996;16:6263-72.
2. Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El-Deiry WS, Tsichlis PN. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myloid cell differentation Mol Cell Bio. 1998;18:2462-73.
3. Saleque S, Cameron S, Orkin SH. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 2002;16:301-6.
4. Vassen L, Okayama T, Möröy T. Gfi1b: Green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1. Blood. 2007;109:2356-64.
5. Osawa M, Yamaguchi T, Nakamura Y, Kaneko S, Ondera M, Sawada K-I, Jegalian A, Wu H, Nakauchi H, Iwama A. Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis Blood. 2002;100:2769-77.
6. Bell DW, Taguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Gilks CB, Zweidler-McKay P, Grimes HL, Tsichlis PN, Testa JR. Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. Cytogenet Cell Genet. 1995;70:263-7.
7. Rodel B, Wagner T, Zornig M, Niessing J, Moroy T. The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34.13-A locus frequently altered in hematopoietic diseases. Genomics. 1998;54:580-2.
8. Elmaagacli AH, Koldehoff M, Zakrzewski JL, Steckel NK, Ottinger H, Beelen DW. Growth factor independence 1B gene (Gfi-1B) is over-expressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Br J Haematol. 2007;136:212-9.
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-8.
10. Elmaagacli AH, Koldehoff M, Peceny R, Klein-Hitpass L, Ottinger H, Beelen DW, Opalka B. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica. 2005;90:326-34.
11. Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH. Synthetics mall interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia (+) acute myeloid leukemia. Clin Exp Med. 2006;6:45-7.
12. Elmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer UW, Beelen DW. Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of bcr-abl fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haemtol. 2001;113:1072-5.
13. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol. 2001;158:419-29.
14. Larramendy ML, Niini T, Elonen E, Nagy B, Ollila J, Vihinen M, Knuutila S. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis Haematologica. 2002;87:569-77.
15. Beissbarth T, Speed TP. GOstat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics. 2004;20:1464-5.
16. Melendez AJ, Allen JM. Phospholipase D and immune receptor signalling. Semin Immunol. 2002;14:49-55.
17. Peschard P, Park M. From Tpr-Met to Met, tuorigenesis and tubes. Oncogene. 2007;26:1276-85.
18. Cook NR, Row PE, Davidson HW. Lysosome associated membrane protein 1 (LAMP1) traffics directly from the TGM to early endosomes. Traffic. 2004;5:685-99.
19. Zhao R, Houry WA. Molecular interaction network of the Hsp90 chaperone system. Adv Exp Med Biol. 2007;594:27-36.
20. Wittinghofer A, Nassar N. How RAS-related proteins talk to their effectors. Trends Biochem Sci. 1996;21:488-91.
21. Baala L, Audollent S, Martinovic J, Ozilou C, Babron MC, Sivanandamoorthy S, Saunier S, Salomon R, Gonzales M, Rattenberry E, Esculpavit C, Toutain A, Moraine C, Parent P, Marcorelles P, Dauge MC, Roume J, Le Merrer M, Meiner V, Meir K, Menez F, Beaufrere AM, Francannet C, Tantau J, Sinico M, Dumez Y, MacDonald F, Munnich A, Lyonnet S, Gubler MC, Genin E, Johnson CA, Vekemans M, Encha-Razavi F, Attie-Bitach T. Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet. 2007;81:170-9.
22. Tong JH, Fant X, Benoit G, Chen SJ, Chen Z, Lanotte M. Genomic organizytion of the JEM-1 (BLZF1) gene on human chromosome 1q24: molecular cloning and analysis of its promoter region. Genomics. 2000;69:380-90.
23. Jung HC, Kim K. Identification of MYCBP as a ß-catenin/LEF-1 target using DNA microarray analysis. Life Sci. 2005;77:1249-62.
24. Ghiselli G. SMC3 knockdown triggers genomic instability and p53 dependent apoptosis in human and zebrafish cells. Mol Cancer. 2006;5:52-65.
25. Jansen JH, Lowenberg B. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein. Semin Hematol. 2001;38:37-41.
26. Allen SJ, Crown SE, Handel TM. Chemokines: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25:787-820.
27. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: AKTing on apoptosis. Cell Signal. 2008;1:21-30.
28. Rodriguez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, Heck AJ, Vyas P, de Boer E, Grosveld F, Strouboulis J. GATA-1 forms distinct activating and repreesive complexes in erythroid cells. EMBO J. 2005;24:2354-66.
29. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19:1-11.
30. Duan Z, Horwitz M. Gfi-1 oncoproteins in hematopoiesis. Hematology. 2003;8:339-44.
31. Garcon L, Lacout C, Svinartchouk F, Le Couedic JP, Villeval JL, Vainchenker W, Dumenil D. Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood. 2005;105:1448-55.